Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Alphyn Biologics
company
About
Alphyn Biologics is a life science company that develops proprietary drug therapy for treating skin diseases.
- 1 - 10
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $3.30M
- Industries
- Health Care,Life Science,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 2019
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Alphyn Biologics is a life science company that develops proprietary drug therapy for treating skin diseases. Alphyn's initial target indication are skin infections caused by deadly drug-resistant MRSA bacteria based on their proprietary Multi-Target Therapeutic (MTT) plant-derived technology platform.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$3.30M
Alphyn Biologics has raised a total of
$3.30M
in funding over 2 rounds. Their latest funding was raised on
Sep 15, 2022 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 15, 2022 | Series A | $3.30M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Alphyn Biologics is funded by 1 investors.
Angel Physicians Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
